Latest N30 Pharmaceuticals Inc. Stories
BOULDER, Colo., Nov. 19, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc.
BOULDER, Colo., March 12, 2014 /PRNewswire/ -- N30 Pharmaceuticals, Inc. ("N30 Pharma") announced today that it has begun oral dosing of N91115 in a Phase 1 clinical trial.
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.